Valuation: UCB

Market Cap 4.14TCr 4.8TCr 3.89TCr 3.54TCr 6.66TCr 4,58900Cr 6.77TCr 46TCr 18TCr 2,30000Cr 18TCr 18TCr 7,65400Cr P/E 2026 *
21.8x
P/E 2027 * 17.9x
Enterprise Value 4.18TCr 4.83TCr 3.92TCr 3.57TCr 6.72TCr 4,62500Cr 6.82TCr 46TCr 18TCr 2,31800Cr 18TCr 18TCr 7,71300Cr EV / Sales 2026 *
4.81x
EV / Sales 2027 * 4.09x
Free-Float
61.59%
Yield 2026 *
0.67%
Yield 2027 * 0.69%
1 day-3.23%
1 week-4.32%
Current month-5.59%
1 month-6.83%
3 months-11.94%
6 months-23.62%
Current year-13.28%
1 week 254.59
Extreme 254.59
263.09
1 month 254.59
Extreme 254.59
295.59
Current year 254.59
Extreme 254.59
345.39
1 year 219.5
Extreme 219.5
345.39
3 years 69.7
Extreme 69.7
345.39
5 years 68.3
Extreme 68.301062
345.39
10 years 58.42
Extreme 58.42
345.39
Manager TitleAgeSince
Chief Executive Officer 67 01/01/2015
Director of Finance/CFO 60 01/07/2020
Chief Tech/Sci/R&D Officer 59 01/05/2024
Director TitleAgeSince
Director/Board Member 55 01/01/2012
Director/Board Member 67 01/01/2015
Director/Board Member 56 24/04/2014
Change 5-day change 1-year change 3-year change Capi.($)
-3.23%-4.32% - - 4.76TCr
+0.65%+0.27%+39.60%+1.70% 8.05TCr
-1.10%-2.42%-3.61%+28.98% 5.06TCr
+0.88%-3.47%+12.88%+166.89% 4.76TCr
+17.25%+17.36%-41.63%-41.46% 4.58TCr
+1.63%+2.62%+53.35%-18.72% 3.09TCr
-2.33%+5.27%+124.70%-40.74% 2.57TCr
-0.02%+1.58%+42.05%+92.29% 2.5TCr
+1.36%-0.67%-0.87%+195.57% 2.12TCr
+1.49%+3.15%+69.69%+123.80% 1.67TCr
Average +1.86%+0.07%+32.91%+56.48% 3.82TCr
Weighted average by Cap. +1.97%-0.61%+25.48%+42.25%

Financials

2026 *2027 *
Net sales 868.8Cr 1.01TCr 816.59Cr 743.13Cr 1.4TCr 96TCr 1.42TCr 9.59TCr 3.75TCr 48TCr 3.78TCr 3.69TCr 1,60500Cr 969.01Cr 1.12TCr 910.77Cr 828.84Cr 1.56TCr 1,07300Cr 1.58TCr 11TCr 4.18TCr 54TCr 4.21TCr 4.12TCr 1,79000Cr
Net income 192.52Cr 222.84Cr 180.95Cr 164.67Cr 309.68Cr 21TCr 314.55Cr 2.13TCr 831.27Cr 11TCr 836.56Cr 818.23Cr 36TCr 232.74Cr 269.4Cr 218.76Cr 199.08Cr 374.39Cr 26TCr 380.27Cr 2.57TCr 1TCr 13TCr 1.01TCr 989.18Cr 43TCr
Net Debt 32Cr 37Cr 30Cr 27Cr 52Cr 3.56TCr 52Cr 354.56Cr 138.69Cr 1.78TCr 139.57Cr 136.52Cr 5.93TCr -179.87Cr -208.19Cr -169.06Cr -153.85Cr -289.33Cr -20TCr -293.87Cr -1.99TCr -776.62Cr -9.99TCr -781.57Cr -764.44Cr -33TCr
Logo UCB
UCB is a global biopharmaceutical company focused on the discovery and development of innovative medicines and solutions to transform the lives of people living with severe diseases of the immune system or of the central nervous system.
Employees
9,000
Date Price Change Volume
14/26/14 $254.59 -3.23% 106
13/26/13 $263.09 +0.67% 16
12/26/12 $261.34 -1.15% 25
11/26/11 $264.38 -0.64% 249
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
20
Last Close Price
217.30EUR
Average target price
285.26EUR
Spread / Average Target
+31.28%

Quarterly revenue - Rate of surprise